What stands out to me is
Their focus on a commercial outcome
Significant interest from Potential Pharmaceutical Partners and their sharing of data with other Pharma Companies which means a lot of countries know of this little Aussie Bio company
So I suggest their is a lot more interest in Biotron than M.M. is revealing at the moment
What say you Lux ... pretty well on the money or not
